首页 > 最新文献

Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology最新文献

英文 中文
Para-Hisian Accessory Pathway: Mapping Using Open-Window and Ablation From the Aortic Cusp. 主动脉旁副通道:利用开窗和主动脉尖消融进行定位。
IF 0.8 Q3 Medicine Pub Date : 2023-07-01 DOI: 10.5543/tkda.2022.08791
Serkan Çay, Özcan Özeke, Fırat Özcan, Meryem Kara, Serkan Topaloğlu
A 28-year-old male with palpitations and a Wolff-Parkinson-White electrocardiographic pattern was referred to our division for ablation. The previous 3 ablation attempts from the right atrioventricular annular side performed at different times in the last year were unsuccessful. His conventional 12-lead surface ECG showed highly possible para-Hisian accessory pathway (AP) localization (Figure 1, Panel A). Prior to mapping, a decapolar catheter was advanced into the coronary sinus for intracardiac reference during activation mapping if orthodromic tachycardia developed. During baseline conditions and also after isoproterenol infusion, no sustainable atrioventricular reentrant tachycardia was induced. The AP effective refractory period was 220 milli seconds during programmed atrial stimulation under isoproterenol infusion. Localization and ablation of APs using a 3D electroanatomic mapping (EAM) system and open-window strategy have been previously defined. 1 The open-window strategy using a 3D EAM system (Carto®3, Biosense Webster Inc., Diamond Bar, Calif, USA) was performed during sinus rhythm. A 20-electrode multipolar mapping catheter with 2 mm inter-electrode distance (Pentaray™ Nav, Biosense Webster Inc.) was used for high-density mapping of the right atrium, tricuspid annulus, and right ventricular. For the open-window strategy, the window-of-interest (WOI) was set according to the surface electrocardiography QRS reference including QRS duration and estimated location of atrial and ventricular intracardiac signals obtained from the multielectrode
{"title":"Para-Hisian Accessory Pathway: Mapping Using Open-Window and Ablation From the Aortic Cusp.","authors":"Serkan Çay, Özcan Özeke, Fırat Özcan, Meryem Kara, Serkan Topaloğlu","doi":"10.5543/tkda.2022.08791","DOIUrl":"10.5543/tkda.2022.08791","url":null,"abstract":"A 28-year-old male with palpitations and a Wolff-Parkinson-White electrocardiographic pattern was referred to our division for ablation. The previous 3 ablation attempts from the right atrioventricular annular side performed at different times in the last year were unsuccessful. His conventional 12-lead surface ECG showed highly possible para-Hisian accessory pathway (AP) localization (Figure 1, Panel A). Prior to mapping, a decapolar catheter was advanced into the coronary sinus for intracardiac reference during activation mapping if orthodromic tachycardia developed. During baseline conditions and also after isoproterenol infusion, no sustainable atrioventricular reentrant tachycardia was induced. The AP effective refractory period was 220 milli seconds during programmed atrial stimulation under isoproterenol infusion. Localization and ablation of APs using a 3D electroanatomic mapping (EAM) system and open-window strategy have been previously defined. 1 The open-window strategy using a 3D EAM system (Carto®3, Biosense Webster Inc., Diamond Bar, Calif, USA) was performed during sinus rhythm. A 20-electrode multipolar mapping catheter with 2 mm inter-electrode distance (Pentaray™ Nav, Biosense Webster Inc.) was used for high-density mapping of the right atrium, tricuspid annulus, and right ventricular. For the open-window strategy, the window-of-interest (WOI) was set according to the surface electrocardiography QRS reference including QRS duration and estimated location of atrial and ventricular intracardiac signals obtained from the multielectrode","PeriodicalId":46993,"journal":{"name":"Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology","volume":null,"pages":null},"PeriodicalIF":0.8,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9813987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Systolic Dysfunction on Clinical and Diagnostic Parameters in Pediatric Patients with Isolated Left Ventricular Non-compaction. 收缩期功能障碍对小儿孤立性左心室非压实性临床及诊断参数的影响。
IF 0.8 Q3 Medicine Pub Date : 2023-07-01 DOI: 10.5543/tkda.2023.09648
Fatma Sevinc Şengul, Pelin Ayyıldız, Sezen Ugan Atik, Sinem Aydin, Alper Güzeltaş, Yakup Ergül

Objective: Left ventricular non-compaction is a rare cardiomyopathy following an early arrest in endomyocardial morphogenesis. This study aimed to present the clinical and electrocardiographic characteristics, diagnostic features, treatment strategies, effects of systolic dysfunction on clinical and diagnostic parameters, and follow-up of pediatric patients diagnosed with left ventricular non-compaction.

Methods: We retrospectively reviewed children with isolated left ventricular non-compaction at Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital from January 2010 to June 2020.

Results: Fifty-five children were diagnosed with left ventricular non-compaction. Thirty-two patients (58.2%) were male, and the median age of presentation was 8.5 years (1 month-17.9 years). The median follow-up of the study was 19 months (1-121 months). Fourteen (25.5%) presented with systolic dysfunction (ejection fraction < 45%), and 2 presented with resuscitated/aborted cardiac arrest. Electrocardiographic abnormalities were present in 78.2%. Fragmented QRS was observed in 6 patients, and QTc duration was 450 milliseconds and above in 17 patients (30.9%). Electrocardiographic abnormalities, low QRS voltage, fragmented QRS, and thrombus were common in patients with ejection fraction < 45% group. Atrial and ventricular arrhythmias (including ventricular fibrillation-VF) were found with similar frequency in both ejection fraction < 45% and ≥45% groups. One patient with a complete atrioventricular block and 1 with long QT syndrome and severe bradycardia underwent permanent pacemaker implantation. Five (9.1%) patients died.

Conclusions: Left ventricular non-compaction has heterogeneous clinical findings in childhood. It is essential to follow-up with the patients closely for the development of ventricular dysfunction or arrhythmias due to the progressive course of the disease. Further studies are needed since life-threatening ventricular arrhythmias can be seen, even in patients with preserved ejection fraction.

目的:左心室不压实是一种罕见的心内膜形态发生早期停止的心肌病。本研究旨在介绍小儿左室非压实的临床和心电图特点、诊断特点、治疗策略、收缩功能障碍对临床和诊断参数的影响以及随访情况。方法:回顾性分析2010年1月至2020年6月在Mehmet Akif Ersoy胸心血管外科培训与研究医院就诊的孤立性左心室不压实患儿。结果:55例患儿被诊断为左心室不压实。32例(58.2%)为男性,中位发病年龄为8.5岁(1个月,17.9岁)。中位随访时间为19个月(1-121个月)。14例(25.5%)出现收缩功能障碍(射血分数< 45%),2例出现复苏/流产的心脏骤停。78.2%的患者出现心电图异常。6例患者QRS片段化,17例(30.9%)QTc持续时间在450毫秒及以上。射血分数< 45%组多见心电图异常、QRS电压低、QRS碎片化、血栓形成。在射血分数< 45%和≥45%组中,房性和室性心律失常(包括室性颤动- vf)的发生率相似。1例完全性房室传导阻滞患者和1例长QT综合征和严重心动过缓患者接受了永久性起搏器植入。5例(9.1%)患者死亡。结论:儿童期左心室不致密性具有不同的临床表现。随着病程的发展,有必要密切随访患者是否出现室性功能障碍或心律失常。需要进一步的研究,因为即使在保留射血分数的患者中也可以看到危及生命的室性心律失常。
{"title":"Effects of Systolic Dysfunction on Clinical and Diagnostic Parameters in Pediatric Patients with Isolated Left Ventricular Non-compaction.","authors":"Fatma Sevinc Şengul, Pelin Ayyıldız, Sezen Ugan Atik, Sinem Aydin, Alper Güzeltaş, Yakup Ergül","doi":"10.5543/tkda.2023.09648","DOIUrl":"10.5543/tkda.2023.09648","url":null,"abstract":"<p><strong>Objective: </strong>Left ventricular non-compaction is a rare cardiomyopathy following an early arrest in endomyocardial morphogenesis. This study aimed to present the clinical and electrocardiographic characteristics, diagnostic features, treatment strategies, effects of systolic dysfunction on clinical and diagnostic parameters, and follow-up of pediatric patients diagnosed with left ventricular non-compaction.</p><p><strong>Methods: </strong>We retrospectively reviewed children with isolated left ventricular non-compaction at Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital from January 2010 to June 2020.</p><p><strong>Results: </strong>Fifty-five children were diagnosed with left ventricular non-compaction. Thirty-two patients (58.2%) were male, and the median age of presentation was 8.5 years (1 month-17.9 years). The median follow-up of the study was 19 months (1-121 months). Fourteen (25.5%) presented with systolic dysfunction (ejection fraction < 45%), and 2 presented with resuscitated/aborted cardiac arrest. Electrocardiographic abnormalities were present in 78.2%. Fragmented QRS was observed in 6 patients, and QTc duration was 450 milliseconds and above in 17 patients (30.9%). Electrocardiographic abnormalities, low QRS voltage, fragmented QRS, and thrombus were common in patients with ejection fraction < 45% group. Atrial and ventricular arrhythmias (including ventricular fibrillation-VF) were found with similar frequency in both ejection fraction < 45% and ≥45% groups. One patient with a complete atrioventricular block and 1 with long QT syndrome and severe bradycardia underwent permanent pacemaker implantation. Five (9.1%) patients died.</p><p><strong>Conclusions: </strong>Left ventricular non-compaction has heterogeneous clinical findings in childhood. It is essential to follow-up with the patients closely for the development of ventricular dysfunction or arrhythmias due to the progressive course of the disease. Further studies are needed since life-threatening ventricular arrhythmias can be seen, even in patients with preserved ejection fraction.</p>","PeriodicalId":46993,"journal":{"name":"Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology","volume":null,"pages":null},"PeriodicalIF":0.8,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9813988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Plaque Components on Fractional Flow Reserve-Derived Computed Tomography in Severe Coronary Stenosis. 斑块成分对严重冠状动脉狭窄患者血流储备分流计算机断层扫描的影响。
IF 0.8 Q3 Medicine Pub Date : 2023-07-01 DOI: 10.5543/tkda.2022.57522
Toshimitsu Tsugu, Kaoru Tanaka, Yuji Nagatomo, Michel De Maeseneer, Johan De Mey

Fractional flow reserve derived from computed tomography decreases across severe coronary stenosis. The diagnostic accuracy of fractional flow reserve-derived computed tomography is high for severe coronary stenosis. In this report, we present a case of no significant fractional flow reserve-derived computed tomography changes even in severe coronary stenosis. A 75-year-old man showed severe stenosis (85% diameter stenosis) in the distal segment of the right coronary artery on both computed tomography angiography and invasive coronary angiography. However, fractional flow reserve-derived from computed tomography showed no significant changes from the proximal (0.97) to the distal (0.95) segments despite the presence of severe stenotic lesion. This patient had different features including the presence of a large acute marginal branch and significantly lower plaque components in the stenotic lesion compared with another patient who had coronary stenosis in the same segment. A large bifurcation branch and/or proportion of plaque components can affect fractional flow reserve-derived from computed tomography hemodynamics.

在严重的冠状动脉狭窄中,计算机断层扫描得出的血流储备分数降低。分数血流储备衍生的计算机断层扫描对严重冠状动脉狭窄的诊断准确性很高。在本报告中,我们提出了一个病例,即使在严重的冠状动脉狭窄中,也没有明显的分数血流储备衍生的计算机断层扫描改变。一位75岁的男性在ct血管造影和有创冠状动脉造影中均表现为右冠状动脉远段严重狭窄(85%直径狭窄)。然而,计算机断层扫描显示,尽管存在严重的狭窄病变,但从近端(0.97)到远端(0.95)段的血流储备分数没有明显变化。与另一名同一节段冠状动脉狭窄的患者相比,该患者具有不同的特征,包括存在较大的急性边缘分支,狭窄病变中的斑块成分明显较低。一个大的分支分支和/或比例的斑块成分可以影响分数血流储备-从计算机断层血流动力学得出。
{"title":"Impact of Plaque Components on Fractional Flow Reserve-Derived Computed Tomography in Severe Coronary Stenosis.","authors":"Toshimitsu Tsugu, Kaoru Tanaka, Yuji Nagatomo, Michel De Maeseneer, Johan De Mey","doi":"10.5543/tkda.2022.57522","DOIUrl":"10.5543/tkda.2022.57522","url":null,"abstract":"<p><p>Fractional flow reserve derived from computed tomography decreases across severe coronary stenosis. The diagnostic accuracy of fractional flow reserve-derived computed tomography is high for severe coronary stenosis. In this report, we present a case of no significant fractional flow reserve-derived computed tomography changes even in severe coronary stenosis. A 75-year-old man showed severe stenosis (85% diameter stenosis) in the distal segment of the right coronary artery on both computed tomography angiography and invasive coronary angiography. However, fractional flow reserve-derived from computed tomography showed no significant changes from the proximal (0.97) to the distal (0.95) segments despite the presence of severe stenotic lesion. This patient had different features including the presence of a large acute marginal branch and significantly lower plaque components in the stenotic lesion compared with another patient who had coronary stenosis in the same segment. A large bifurcation branch and/or proportion of plaque components can affect fractional flow reserve-derived from computed tomography hemodynamics.</p>","PeriodicalId":46993,"journal":{"name":"Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology","volume":null,"pages":null},"PeriodicalIF":0.8,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9823519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term Observational Study of the Isolated Ostial Diagonal Stenosis in Patients with Chronic Coronary Syndrome. 慢性冠脉综合征患者孤立性口对角狭窄的长期观察研究。
IF 0.8 Q3 Medicine Pub Date : 2023-07-01 DOI: 10.5543/tkda.2023.74422
Akın Torun, Burak Acar, Göksel Kahraman, Ertan Ural, Teoman Kılıç, Umut Çelikyurt, Aysen Ağır

Objective: Isolated ostial diagonal stenoses are very rare lesions in which percutaneous intervention could cause significant vessel compromise, and the long-term results have been reported in a few studies. This study sought the characteristics and long-term follow-up of the patients with isolated osteal diagonal stenosis regarding percutaneous coronary intervention and presence of angina.

Methods: The study was an observational retrospective study conducted between January 2014 and December 2020. A total of 9769 patients who underwent coronary angiography were analyzed, and 87 patients had isolated diagonal stenosis. The patients were evaluated according to treatment modality and angina severity in long-term pattern.

Results: Median follow-up time was 36 months. A total of 54 (83.1%) patients were followed up with only medical treatment, and 11 (16.9%) patients underwent revascularization in addition to medical treatment. The degree of stenosis of the diagonal artery was significantly higher in the percutaneous coronary intervention group than medical group (P = 0.002) and the patients with wider reference diameter of diagonal artery complaint of more angina (P = 0.007). Class I angina was significantly higher in percutaneous coronary intervention group than medical and the patients with no angina were significantly higher in medical group than percutaneous coronary intervention group.

Conclusion: Percutaneous coronary intervention was mainly performed for diagonal arteries with a higher degree of stenosis; however, the patients who underwent percutaneous coronary intervention had angina more than 50% rates. Furthermore, the patients with ongoing angina had a larger diameter of the diagonal artery regardless of the type of treatment.

目的:孤立性口对角狭窄是一种非常罕见的病变,经皮介入治疗可导致严重的血管损害,少数研究报道了其长期结果。本研究旨在探讨经皮冠状动脉介入治疗和心绞痛的孤立性骨对角狭窄患者的特点和长期随访。方法:2014年1月至2020年12月进行观察性回顾性研究。我们共分析了9769例冠状动脉造影患者,其中87例患者有孤立的对角狭窄。根据治疗方式和长期心绞痛严重程度对患者进行评价。结果:中位随访时间36个月。54例(83.1%)患者仅接受药物治疗,11例(16.9%)患者在接受药物治疗的同时接受了血运重建术。经皮冠状动脉介入治疗组对角动脉狭窄程度明显高于药物组(P = 0.002),对角动脉参考直径较宽的患者心绞痛发生率较高(P = 0.007)。经皮冠状动脉介入治疗组ⅰ类心绞痛发生率明显高于药物组,无心绞痛发生率明显高于药物组。结论:经皮冠状动脉介入治疗主要针对狭窄程度较高的对角动脉;然而,经皮冠状动脉介入治疗的患者心绞痛发生率超过50%。此外,无论治疗方式如何,持续心绞痛患者的斜动脉直径都较大。
{"title":"Long-Term Observational Study of the Isolated Ostial Diagonal Stenosis in Patients with Chronic Coronary Syndrome.","authors":"Akın Torun, Burak Acar, Göksel Kahraman, Ertan Ural, Teoman Kılıç, Umut Çelikyurt, Aysen Ağır","doi":"10.5543/tkda.2023.74422","DOIUrl":"10.5543/tkda.2023.74422","url":null,"abstract":"<p><strong>Objective: </strong>Isolated ostial diagonal stenoses are very rare lesions in which percutaneous intervention could cause significant vessel compromise, and the long-term results have been reported in a few studies. This study sought the characteristics and long-term follow-up of the patients with isolated osteal diagonal stenosis regarding percutaneous coronary intervention and presence of angina.</p><p><strong>Methods: </strong>The study was an observational retrospective study conducted between January 2014 and December 2020. A total of 9769 patients who underwent coronary angiography were analyzed, and 87 patients had isolated diagonal stenosis. The patients were evaluated according to treatment modality and angina severity in long-term pattern.</p><p><strong>Results: </strong>Median follow-up time was 36 months. A total of 54 (83.1%) patients were followed up with only medical treatment, and 11 (16.9%) patients underwent revascularization in addition to medical treatment. The degree of stenosis of the diagonal artery was significantly higher in the percutaneous coronary intervention group than medical group (P = 0.002) and the patients with wider reference diameter of diagonal artery complaint of more angina (P = 0.007). Class I angina was significantly higher in percutaneous coronary intervention group than medical and the patients with no angina were significantly higher in medical group than percutaneous coronary intervention group.</p><p><strong>Conclusion: </strong>Percutaneous coronary intervention was mainly performed for diagonal arteries with a higher degree of stenosis; however, the patients who underwent percutaneous coronary intervention had angina more than 50% rates. Furthermore, the patients with ongoing angina had a larger diameter of the diagonal artery regardless of the type of treatment.</p>","PeriodicalId":46993,"journal":{"name":"Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology","volume":null,"pages":null},"PeriodicalIF":0.8,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9823525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effects of Vitamin D on Myocardial Function Demonstrated by Speckle-Tracking Echocardiography in Children with Beta Thalassemia. 斑点追踪超声心动图显示维生素D对地中海贫血儿童心肌功能的影响。
IF 0.8 Q3 Medicine Pub Date : 2023-07-01 DOI: 10.5543/tkda.2023.85265
Ayça Koca Yozgat, Emine Azak, Dilek Kaçar, Melek Işık, Özlem Arman Bilir, Zeliha Güzelküçük, İbrahim İlker Çetin, Namık Yaşar Özbek, Neşe Yaralı

Objective: Beta thalassemia major is an inherited hemoglobin disorder resulting in chronic hemolytic anemia. Cardiac involvement is the main cause of death in patients. Speckle-tracking echocardiography is a feasible method for the evaluation of cardiac function via an assessment of the longitudinal deformation of the myocardium through the cardiac cycle. The aim of our study is to evaluate the association between vitamin D deficiency and deformation of the left ventricular myocardium measured by speckle-tracking echocardiography in children with thalassemia major.

Methods: In this prospective study, 33 thalassemic patients with vitamin D deficiency were enrolled. Cardiac magnetic resonance T2* value, conventional echocardiography, and speckle tracking, and also left ventricular longitudinal and circumferential strain values were measured. Myocardial functions of the patients with vitamin D deficiency or insufficiency were evaluated by speckle-tracking echocardiography before and after vitamin D replacement.

Results: The mean age of the patients was 15.4 ± 3.09 years. Vitamin D level was deficient in 30 (90%) and insufficient in 3 (10%) of them. Speckle-tracking analysis showed a significantly decreased absolute value of the left ventricular global longitudinal strain before vitamin D replacement. A significant improvement in the global longitudinal strain was detected after vitamin D replacement (P < 0.05). A statistically significant increase was observed in parameters showing left ventricular systolic and diastolic functions after vitamin D replacement.

Conclusion: Vitamin D deficiency is frequently observed and causes decreased contractility in thalassemic patients. In our study, we observed that our patients' cardiac functions had improved after vitamin D replacement therapy.

目的:乙型地中海贫血是一种遗传性血红蛋白疾病,导致慢性溶血性贫血。心脏受累是患者死亡的主要原因。斑点跟踪超声心动图是一种可行的方法,通过评估心脏周期中心肌的纵向变形来评估心功能。我们的研究目的是评估维生素D缺乏与斑点跟踪超声心动图测量的地中海贫血儿童左心室心肌变形之间的关系。方法:在这项前瞻性研究中,33例地中海贫血维生素D缺乏症患者入组。测量心脏磁共振T2*值、常规超声心动图、斑点跟踪及左室纵、周应变值。采用斑点追踪超声心动图评价维生素D缺乏或不足患者在补充维生素D前后的心肌功能。结果:患者平均年龄15.4±3.09岁。其中30人(90%)缺乏维生素D, 3人(10%)缺乏维生素D。斑点跟踪分析显示,维生素D替代前左心室整体纵向应变绝对值显著降低。维生素D替代后整体纵向应变有显著改善(P < 0.05)。在维生素D替代后,左心室收缩和舒张功能的参数有统计学意义的增加。结论:维生素D缺乏是地中海贫血患者经常观察到的,并导致收缩能力下降。在我们的研究中,我们观察到患者的心脏功能在维生素D替代治疗后得到了改善。
{"title":"The Effects of Vitamin D on Myocardial Function Demonstrated by Speckle-Tracking Echocardiography in Children with Beta Thalassemia.","authors":"Ayça Koca Yozgat, Emine Azak, Dilek Kaçar, Melek Işık, Özlem Arman Bilir, Zeliha Güzelküçük, İbrahim İlker Çetin, Namık Yaşar Özbek, Neşe Yaralı","doi":"10.5543/tkda.2023.85265","DOIUrl":"10.5543/tkda.2023.85265","url":null,"abstract":"<p><strong>Objective: </strong>Beta thalassemia major is an inherited hemoglobin disorder resulting in chronic hemolytic anemia. Cardiac involvement is the main cause of death in patients. Speckle-tracking echocardiography is a feasible method for the evaluation of cardiac function via an assessment of the longitudinal deformation of the myocardium through the cardiac cycle. The aim of our study is to evaluate the association between vitamin D deficiency and deformation of the left ventricular myocardium measured by speckle-tracking echocardiography in children with thalassemia major.</p><p><strong>Methods: </strong>In this prospective study, 33 thalassemic patients with vitamin D deficiency were enrolled. Cardiac magnetic resonance T2* value, conventional echocardiography, and speckle tracking, and also left ventricular longitudinal and circumferential strain values were measured. Myocardial functions of the patients with vitamin D deficiency or insufficiency were evaluated by speckle-tracking echocardiography before and after vitamin D replacement.</p><p><strong>Results: </strong>The mean age of the patients was 15.4 ± 3.09 years. Vitamin D level was deficient in 30 (90%) and insufficient in 3 (10%) of them. Speckle-tracking analysis showed a significantly decreased absolute value of the left ventricular global longitudinal strain before vitamin D replacement. A significant improvement in the global longitudinal strain was detected after vitamin D replacement (P < 0.05). A statistically significant increase was observed in parameters showing left ventricular systolic and diastolic functions after vitamin D replacement.</p><p><strong>Conclusion: </strong>Vitamin D deficiency is frequently observed and causes decreased contractility in thalassemic patients. In our study, we observed that our patients' cardiac functions had improved after vitamin D replacement therapy.</p>","PeriodicalId":46993,"journal":{"name":"Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology","volume":null,"pages":null},"PeriodicalIF":0.8,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9823521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Focusing on Cardio-Hepatic Syndrome in Heart Failure and Cardiovascular Interventions: Time to Update the Prognostic Risk Scores? 心衰中的肝心综合征和心血管干预:是时候更新预后风险评分了吗?
IF 0.8 Q3 Medicine Pub Date : 2023-07-01 DOI: 10.5543/tkda.2023.25425
Oğuz Karaca
H eart failure (HF) is a multifactorial, heterogeneous disease characterized by congestion and/or reduced cardiac output, leading to unmet metabolic demands of vital organs. Regardless of the etiology or phenotypic features (ischemic vs. non-ischemic, reduced or preserved ejection fraction, severe valvular stenosis or regurgitation), the “inevitable consequence” of the HF syndrome is the progressive end-organ dysfunction. Failure of one or more organ systems (heart itself, lungs, kidneys, liver, intestine, brain, skeletal muscle) has been the main determinant of survival in HF. 1,2 Integration of new pharmacologic agents (saqubitril/valsartan, sodium-glucose cotransporter-2 (SGLT-2) inhibitors) into guideline-directed medical therapy and advancements in interventional and surgical procedures (complex coronary interventions, transcatheter aortic valve implantation (TAVI), Mitra-clip, left ventricular assist devices) have led to a significant improvement in HF mortality in selected patients. 3-7 However, HF still remains a global health problem associated with reduced survival, frequent hospitalizations, and impaired quality of life.
{"title":"Focusing on Cardio-Hepatic Syndrome in Heart Failure and Cardiovascular Interventions: Time to Update the Prognostic Risk Scores?","authors":"Oğuz Karaca","doi":"10.5543/tkda.2023.25425","DOIUrl":"10.5543/tkda.2023.25425","url":null,"abstract":"H eart failure (HF) is a multifactorial, heterogeneous disease characterized by congestion and/or reduced cardiac output, leading to unmet metabolic demands of vital organs. Regardless of the etiology or phenotypic features (ischemic vs. non-ischemic, reduced or preserved ejection fraction, severe valvular stenosis or regurgitation), the “inevitable consequence” of the HF syndrome is the progressive end-organ dysfunction. Failure of one or more organ systems (heart itself, lungs, kidneys, liver, intestine, brain, skeletal muscle) has been the main determinant of survival in HF. 1,2 Integration of new pharmacologic agents (saqubitril/valsartan, sodium-glucose cotransporter-2 (SGLT-2) inhibitors) into guideline-directed medical therapy and advancements in interventional and surgical procedures (complex coronary interventions, transcatheter aortic valve implantation (TAVI), Mitra-clip, left ventricular assist devices) have led to a significant improvement in HF mortality in selected patients. 3-7 However, HF still remains a global health problem associated with reduced survival, frequent hospitalizations, and impaired quality of life.","PeriodicalId":46993,"journal":{"name":"Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology","volume":null,"pages":null},"PeriodicalIF":0.8,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10199587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How to Manage Implantable Cardiac Defibrillator Protection in an Implantable Cardiac Defibrillator-Dependent Patient Undergoing Palliative Radiotherapy? 如何在接受姑息性放射治疗的依赖植入式心脏除颤器的患者中管理植入式心脏起搏器保护?
IF 0.8 Q3 Medicine Pub Date : 2023-07-01 DOI: 10.5543/tkda.2022.45062
Cihan Öztürk, Efe Yılmaz, Gökay Taylan, Murat Gök, Kenan Yalta
A 61-year-old female patient underwent left breast segmental mastectomy for invasive ductal carcinoma in 2011. Thereafter, trastuzumab therapy was initiated as an adjuvant chemotherapy. However, trastuzumab-related cardiotoxicity developed leading to a left ventricular ejection fraction (LVEF) value of 25% in the patient. Notably, LVEF did not improve with optimal medical treatment on follow-up. Therefore, decision-making for an implantable cardiac defibrillator (ICD) therapy (for primary prevention) was implemented. Implantable cardiac defibrillator was implanted in the right pectoral region due to left mastectomy and lymph node excision. On follow-up, positron emission computed tomography revealed metastatic lesions involving the anterior upper lobe of the right lung and right infraclavicular lymph nodes. The patient was referred to our clinics due to the fact that she had an ICD generator in the vicinity of the metastatic sites (Figure 1A). This might substantially reduce the effectiveness of planned radiotherapy on this region. Moreover, radiotherapy with a cumulative dose of >5 Gy might potentially hamper the ICD generator. Notably, the calculated dose was seemingly over this threshold according to the American Association of Physicists in Medicine Task Group 203. Based on the abovementioned challenges, temporary removal of the ICD generator, leaving the leads in place, and reimplantation of the generator in the same region following radiotherapy were considered. However, even though the patient was not dependent on cardiac pacing by the device, the patient might be
{"title":"How to Manage Implantable Cardiac Defibrillator Protection in an Implantable Cardiac Defibrillator-Dependent Patient Undergoing Palliative Radiotherapy?","authors":"Cihan Öztürk, Efe Yılmaz, Gökay Taylan, Murat Gök, Kenan Yalta","doi":"10.5543/tkda.2022.45062","DOIUrl":"10.5543/tkda.2022.45062","url":null,"abstract":"A 61-year-old female patient underwent left breast segmental mastectomy for invasive ductal carcinoma in 2011. Thereafter, trastuzumab therapy was initiated as an adjuvant chemotherapy. However, trastuzumab-related cardiotoxicity developed leading to a left ventricular ejection fraction (LVEF) value of 25% in the patient. Notably, LVEF did not improve with optimal medical treatment on follow-up. Therefore, decision-making for an implantable cardiac defibrillator (ICD) therapy (for primary prevention) was implemented. Implantable cardiac defibrillator was implanted in the right pectoral region due to left mastectomy and lymph node excision. On follow-up, positron emission computed tomography revealed metastatic lesions involving the anterior upper lobe of the right lung and right infraclavicular lymph nodes. The patient was referred to our clinics due to the fact that she had an ICD generator in the vicinity of the metastatic sites (Figure 1A). This might substantially reduce the effectiveness of planned radiotherapy on this region. Moreover, radiotherapy with a cumulative dose of >5 Gy might potentially hamper the ICD generator. Notably, the calculated dose was seemingly over this threshold according to the American Association of Physicists in Medicine Task Group 203. Based on the abovementioned challenges, temporary removal of the ICD generator, leaving the leads in place, and reimplantation of the generator in the same region following radiotherapy were considered. However, even though the patient was not dependent on cardiac pacing by the device, the patient might be","PeriodicalId":46993,"journal":{"name":"Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology","volume":null,"pages":null},"PeriodicalIF":0.8,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9813991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Cardiac CT and Circulating Biomarkers in Coronary Artery Disease: Recent Advances for Expanding Cardiac Imaging Access. 心脏CT和循环生物标志物在冠状动脉疾病中的作用:扩大心脏成像途径的最新进展。
IF 0.8 Q3 Medicine Pub Date : 2023-06-01 DOI: 10.5543/tkda.2023.00557
İbrahim Altun
{"title":"Role of Cardiac CT and Circulating Biomarkers in Coronary Artery Disease: Recent Advances for Expanding Cardiac Imaging Access.","authors":"İbrahim Altun","doi":"10.5543/tkda.2023.00557","DOIUrl":"https://doi.org/10.5543/tkda.2023.00557","url":null,"abstract":"","PeriodicalId":46993,"journal":{"name":"Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology","volume":null,"pages":null},"PeriodicalIF":0.8,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10049700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effects of Curcumin on Mechanical Functions and Cardiac Contractility in Isolated Rat Hearts. 姜黄素对离体大鼠心脏机械功能和心脏收缩力的影响。
IF 0.8 Q3 Medicine Pub Date : 2023-06-01 DOI: 10.5543/tkda.2022.69765
Özden Kutlay, Bilgin Kaygısız, Arzu Keskin Aktan

Objective: Curcumin is a bioactive compound that has well-known pharmacological activities. Numerous studies have shown that curcumin provides potential cardiovascular benefits through a variety of mechanisms.The present study aims to discuss different concentrations of curcumin's impact on mechanical functions and cardiac contractility in isolated perfused rat hearts.

Methods: The hearts were isolated under sodium thiopental (50 mg/kg) anesthesia and perfused with a modified Krebs-Henseleit solution (mK-Hs). After stabilization, curcumin was applied in concentrations of 0.1, 1, and 10 µM. In isolated rat hearts, indexes of + dP / dt max, LVDP, MAP, and LVEDP were evaluated for cardiac contractility and ventricular function.

Results: All curcumin concentrations reduced +dP/dtmax and LVDP. Ten µM curcumin also significantly decreased heart rate. Curcumin (1 and 10 µM) increased LVEDP and reduced MAP amplitude with a concomitant increase in MAP duration. Curcumin at all concentrations did not affect dMAPdtmax and dMAPdtmin.

Conclusion: Our results might suggest that curcumin at higher concentrations (≥ 1 µM) increases LVEDP with a negative chronotropic effect and decreases MAP amplitude with an increase in MAP duration. There is sufficient evidence from this study that Curcumin possesses an adverse inotropic action. Different disease models should support the pathophysiological role of Curcumin on cardiac contraction.

目的:姜黄素是一种具有药理活性的生物活性化合物。大量研究表明,姜黄素通过多种机制提供潜在的心血管益处。本研究旨在探讨不同浓度姜黄素对离体灌注大鼠心脏机械功能和心脏收缩力的影响。方法:在硫喷妥钠(50 mg/kg)麻醉下离体心脏,经改良的Krebs-Henseleit溶液(mK-Hs)灌注。稳定后,以0.1、1和10µM的浓度施加姜黄素。在离体大鼠心脏中,评估+ dP / dt max、LVDP、MAP和LVEDP指标对心脏收缩力和心室功能的影响。结果:姜黄素浓度降低+dP/dtmax和LVDP。10µM姜黄素也显著降低心率。姜黄素(1µM和10µM)增加LVEDP,降低MAP振幅,同时增加MAP持续时间。所有浓度的姜黄素均不影响dMAPdtmax和dMAPdtmin。结论:较高浓度姜黄素(≥1µM)可使LVEDP呈负变时效应增加,MAP振幅随MAP持续时间的增加而降低。本研究有充分证据表明姜黄素具有不良的肌力作用。不同的疾病模型应该支持姜黄素对心脏收缩的病理生理作用。
{"title":"The Effects of Curcumin on Mechanical Functions and Cardiac Contractility in Isolated Rat Hearts.","authors":"Özden Kutlay,&nbsp;Bilgin Kaygısız,&nbsp;Arzu Keskin Aktan","doi":"10.5543/tkda.2022.69765","DOIUrl":"https://doi.org/10.5543/tkda.2022.69765","url":null,"abstract":"<p><strong>Objective: </strong>Curcumin is a bioactive compound that has well-known pharmacological activities. Numerous studies have shown that curcumin provides potential cardiovascular benefits through a variety of mechanisms.The present study aims to discuss different concentrations of curcumin's impact on mechanical functions and cardiac contractility in isolated perfused rat hearts.</p><p><strong>Methods: </strong>The hearts were isolated under sodium thiopental (50 mg/kg) anesthesia and perfused with a modified Krebs-Henseleit solution (mK-Hs). After stabilization, curcumin was applied in concentrations of 0.1, 1, and 10 µM. In isolated rat hearts, indexes of + dP / dt max, LVDP, MAP, and LVEDP were evaluated for cardiac contractility and ventricular function.</p><p><strong>Results: </strong>All curcumin concentrations reduced +dP/dtmax and LVDP. Ten µM curcumin also significantly decreased heart rate. Curcumin (1 and 10 µM) increased LVEDP and reduced MAP amplitude with a concomitant increase in MAP duration. Curcumin at all concentrations did not affect dMAPdtmax and dMAPdtmin.</p><p><strong>Conclusion: </strong>Our results might suggest that curcumin at higher concentrations (≥ 1 µM) increases LVEDP with a negative chronotropic effect and decreases MAP amplitude with an increase in MAP duration. There is sufficient evidence from this study that Curcumin possesses an adverse inotropic action. Different disease models should support the pathophysiological role of Curcumin on cardiac contraction.</p>","PeriodicalId":46993,"journal":{"name":"Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology","volume":null,"pages":null},"PeriodicalIF":0.8,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10049699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Comments on Cardiology]. 【心脏病学评论】。
Ertan Ural
{"title":"[Comments on Cardiology].","authors":"Ertan Ural","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":46993,"journal":{"name":"Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology","volume":null,"pages":null},"PeriodicalIF":0.8,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10032098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1